Larvol Delta - ARGX1132207-A-Study-of-Efgartigimod-PH20-SC-in-Children-Between-2-and-Less-Than-18-Years-of-Age-With-Generalized-Myasthenia-Gravis

Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) - argenx

http://clinicaltrials.gov/ct2/show/NCT06392386

Sep 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next